Related Experiment Videos

Cells responsible for tumor surveillance in man: effects of radiotherapy, chemotherapy, and biologic response

Advances in Immunity and Cancer Therapy
|January 1, 1985
PubMed

Insights

Tumor surveillance likely involves antigen-independent immune effects from cells like macrophages and NK cells, not just T-cells. Treatments modulate this system, with NK cells potentially playing a key surveillance role.

Area of Science:

  • Immunology
  • Oncology

Background:

  • Current tumor surveillance theories are debated, with evidence against solely antigen-dependent T-cell responses.
  • A probable model involves antigen-independent mechanisms like nutritional immunity, cytokines, and cytotoxic cells.

Purpose of the Study:

  • To explore the mechanisms of tumor surveillance and the impact of cancer treatments on immune cells.
  • To investigate the role of antigen-independent immune effects in cancer defense.

Main Methods:

  • Review of existing theories on tumor surveillance.
  • Analysis of immune cell functions (macrophages, NK cells, T-cells) following radiotherapy and chemotherapy.
  • Evaluation of Bestatin's effects on immune parameters and patient survival.

Main Results:

  • Radiotherapy and chemotherapy differentially affect immune cells, with NK cell activity remaining robust or elevated post-treatment.
  • NK cell activity and T-helper/T-suppressor cell ratios show changes post-chemotherapy, suggesting a role for NK cells in surveillance.
  • Bestatin enhances NK cell activity and phagocytic capacity, correlating with improved survival in certain cancer patients.

Conclusions:

  • Tumor surveillance is likely mediated by a combination of antigen-independent cellular and humoral effects.
  • NK cells may play a significant role in tumor surveillance, as indicated by their persistent activity post-treatment.
  • Immunomodulatory agents like Bestatin show promise in enhancing anti-tumor immunity and patient outcomes.

Related Concept Videos